These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 30192303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
    Paoluzzi L, Hanniford D, Sokolova E, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E.
    Cancer Med; 2016 Jun; 5(6):1183-93. PubMed ID: 27169980
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
    Xiao J, Egger ME, McMasters KM, Hao H.
    BMC Cancer; 2018 Jun 22; 18(1):675. PubMed ID: 29929490
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma.
    Kulkarni A, Al-Hraishawi H, Simhadri S, Hirshfield KM, Chen S, Pine S, Jeyamohan C, Sokol L, Ali S, Teo ML, White E, Rodriguez-Rodriguez L, Mehnert JM, Ganesan S.
    Clin Cancer Res; 2017 Sep 15; 23(18):5631-5638. PubMed ID: 28539463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells.
    Bokharaie H, Kolch W, Krstic A.
    Biomolecules; 2022 Jul 17; 12(7):. PubMed ID: 35883549
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma Cells.
    Luo H, Umebayashi M, Doi K, Morisaki T, Shirasawa S, Tsunoda T.
    Anticancer Res; 2016 Jul 17; 36(7):3585-9. PubMed ID: 27354627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation.
    Rathod D, Fu Y, Patel K.
    Eur J Pharm Sci; 2019 Oct 01; 138():105039. PubMed ID: 31394259
    [Abstract] [Full Text] [Related]

  • 15. Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
    Romano E, Pradervand S, Paillusson A, Weber J, Harshman K, Muehlethaler K, Speiser D, Peters S, Rimoldi D, Michielin O.
    Clin Cancer Res; 2013 Oct 15; 19(20):5749-57. PubMed ID: 23948972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.
    Molnár E, Garay T, Donia M, Baranyi M, Rittler D, Berger W, Tímár J, Grusch M, Hegedűs B.
    Int J Mol Sci; 2019 Sep 11; 20(18):. PubMed ID: 31514305
    [Abstract] [Full Text] [Related]

  • 19. Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH.
    Ruzzolini J, Peppicelli S, Andreucci E, Bianchini F, Margheri F, Laurenzana A, Fibbi G, Pimpinelli N, Calorini L.
    Cancer Lett; 2017 Nov 01; 408():43-54. PubMed ID: 28826720
    [Abstract] [Full Text] [Related]

  • 20. LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells.
    Han S, Yan Y, Ren Y, Hu Y, Wang Y, Chen L, Zhi Z, Zheng Y, Shao Y, Liu J.
    Cancer Res; 2021 Jun 01; 81(11):2918-2929. PubMed ID: 34087780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.